Tuesday, May 4, 2010
Merck Notch Pathway Blocker...
Okay Folks,
I have been doing a little research on the clinical trial that Kari may participate in. From a cursory look, it is promising.
This link will take you to an article from late last year that gives a good overview.
http://www.reuters.com/article/idUSTRE5BD3AD20091214
Here are the Cliff Notes:
Studies in animals and women with advanced breast cancer showed the experimental compound MK-0752, under development by Merck & Co Inc, was able to kill off cancer stem cells that linger in the breast after chemotherapy.
Other articles talk about how the combined cocktail of MK-0752 and traditional chemotherapies dramatically reduce the likelihood of the cancer returning later in life.
I'll post more on this as we learn more.
Jay
Subscribe to:
Post Comments (Atom)
2 comments:
Thank you for the cliff notes on the new drug Jay. It sounds like it is advancing cancer treatment in a very positive direction!
Kari and Jay (and James and Katie, too)
I've been thinking about you a ton, especially on Thurs when i know you had a bunch of tests, Kari. Know that our thoughts and prayers are with you, and that we are here if you need us. We want all good things for you and your family. Be well.
Deanna
Post a Comment